Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2020 07:30 ET | Source: Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics to Present at Two Investor Conferences in March

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and...
January 08, 2020 07:00 ET | Source: Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Appoints Steve Hughes, M.D., as Chief Development Officer

SAN DIEGO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and...
November 07, 2019 16:01 ET | Source: Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
November 07, 2019 07:30 ET | Source: Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Expands Platform with STARR Technology™

SAN DIEGO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT, the “Company”), a leading messenger RNA medicines company focused on the discovery, development and...
November 04, 2019 07:30 ET | Source: Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics to Report Corporate Overview and Financial Results on November 7th

SAN DIEGO, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of...
October 02, 2019 09:00 ET | Source: Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics to Present at Three Upcoming Investor Conferences

SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
September 26, 2019 08:00 ET | Source: Arcturus Therapeutics Holdings Ltd

Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock

SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of mRNA...
September 23, 2019 08:00 ET | Source: Arcturus Therapeutics Holdings Ltd

Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. and Re-Appointment of Andy Sassine to the Board of Directors

SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
August 26, 2019 08:00 ET | Source: Arcturus Therapeutics Holdings Ltd

Arcturus Therapeutics To Present at Two Investor Conferences in September

SAN DIEGO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
August 15, 2019 08:00 ET | Source: Arcturus Therapeutics Holdings Ltd

Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update

Ultragenyx Pharmaceutical, Inc. expands collaboration, becoming Arcturus’ largest shareholderCystic Fibrosis Foundation increases commitment to $15 millionArcturus receives Orphan Drug Designation...